Mylan CEO: Neulasta biosimilar will offer "significant savings" for patients

It's been nearly two years since the pharmaceutical giant took tremendous heat for the rising cost of EpiPens

Source: Health News: CBSNews.com - June 12, 2018 Category: Consumer Health News Source Type: news